Skip to main content
Clinical Trials/NCT01256970
NCT01256970
Completed
Not Applicable

The Study of Polycystic Ovary Syndrome (PCOS) and Questionnaire

Taipei Medical University WanFang Hospital1 site in 1 country306 target enrollmentNovember 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Polycystic Ovary Syndrome
Sponsor
Taipei Medical University WanFang Hospital
Enrollment
306
Locations
1
Primary Endpoint
Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome.
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Polycystic ovary syndrome (PCOS) is an extremely common disorder in women of reproductive age. Diagnosis of PCOS is principally based on clinical and physical findings. Diagnostic criteria and PCOS definitions used by clinicians and researchers are almost as heterogeneous as the syndrome. This first part of study is determine whether genetic polymorphisms influence hormonal and metabolic characteristics in Taiwanese patients with PCOS and controls. Furthermore, women with PCOS were reported with high risk of cardiovascular disease, the investigators planned to calculate the difference of carotid intima-media thickness (IMT) and B-type natriuretic peptide (BNP) between women with PCOS and normal control to determine the premature atherosclerosis of women with PCOS.

Registry
clinicaltrials.gov
Start Date
November 2010
End Date
January 2013
Last Updated
12 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ming-I Hsu

Attending Doctor

Taipei Medical University WanFang Hospital

Eligibility Criteria

Inclusion Criteria

  • women at reproductive age
  • women with PCOS and women without PCOS

Exclusion Criteria

  • young women who had their menarche less than 3 years
  • women older than 45 years old, Amenorrhea of menopause, hyperglycemia, hyperthyroidism, hypothyroidism, heart failure, lung failure, renal failure, anemia, dystrophy, gonitis

Outcomes

Primary Outcomes

Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome.

Time Frame: Prospectively study in University teaching hospital from 31 August 2010 to 31 August 2011.

To evaluate the contribution to glucose intolerance and metabolic syndrome of obesity combined with the diagnostic criteria of polycystic ovary syndrome (PCOS).

Study Sites (1)

Loading locations...

Similar Trials